FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
Note: If you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction, it is critical to contact a healthcare provider immediately
Its a legitimate, intelligent question
Exp Neurol 392:115328
1,2,6,12 Dementia-like disease, including episodes of psychosis, is thought to be associated with more severe and chronic deficiency, although supporting evidence is poor
Weight loss typically accelerates during this period, with most researchers reporting 4-8% body weight reduction by week 12